In silico pharmacological evaluation of a multi-epitope vaccine candidate targeting the G1 and G2 glycoproteins of Oropouche virus via TLR3 interaction.
Aug 2026· Naunyn-Schmiedeberg's Archives of Pharmacology· 0 citations· 47 references
Medicine
TL;DR
Findings indicate that the G1-based multi-epitope vaccine is a potential candidate for further experimental validation and may serve as an effective preventive strategy against OROV infection.
Human metapneumovirus (HMPV) is a leading cause of acute respiratory tract infections in infants, older adults, and immunocompromised individuals; however, no licensed vaccine is currently available. This study employed an immunoinformatics-guided reverse vaccinology approach to design novel BAFF- and APRIL-adjuvan...
Reham M. Alahmadi, M. Awadalla, Halah Z. AlRawi et al.· Frontiers in Virology· 0 citations
Usutu virus is an emerging mosquito-borne flavivirus with an expanding geographic distribution and increasing public health relevance, yet no licensed vaccine is currently available. This study used an integrated reverse vaccinology strategy to identify conserved immunogenic regions from the Envelope protein and NS5 pr...
Reem Alromaihi, H. Alharbi, S. Almerdasi et al.· Microorganisms· 0 citations
Rift Valley fever virus (RVFV) is a major zoonotic pathogen causing significant outbreaks in humans and livestock, with no licensed effective vaccines currently available. This study employed reverse vaccinology and immunoinformatics approaches to design three multi-epitope mRNA vaccine candidates against RVFV. Conserv...
E. K. Oladipo, James Akinwumi Ogunniran, Biobele Winner Sokari et al.· Discover Immunity· 0 citations
The rationally designed multi-epitope vaccine demonstrates robust theoretical potential to elicit comprehensive, long-lasting immunity in humans, although its safety and effectiveness require additional experimental validation.
Chenchen Yi, Yu Shen, Ye Luo et al.· Frontiers in Cellular and In...· 0 citations
Epstein–Barr virus (EBV)–associated gastric cancer (EBVaGC) is distinct molecular subtype of gastric cancer for which effective preventive and targeted therapeutic strategies remain limited. This study aimed to design and evaluate multiepitope vaccine candidates targeting four EBV proteins critically involved in this d...
Elvin Delonio, Y. Ysrafil, Herlina Eka Shinta et al.· Journal of the Egyptian Nati...· 0 citations
The proposed multi-epitope vaccine shows promising immunological and structural properties, supporting its potential against S. typhimurium, pending experimental validation.
Mohammed Naveez Valathoor, A. P. Rajan· Scientific Reports· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.